A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Incyte Corporation
Incyte Corporation
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Goethe University
Dana-Farber Cancer Institute
University of California, San Diego
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Amgen
Janssen Research & Development, LLC
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University College, London
Children's Oncology Group
National Cancer Institute (NCI)
Technische Universität Dresden
M.D. Anderson Cancer Center
Universitätsklinikum Hamburg-Eppendorf
M.D. Anderson Cancer Center
Children's Oncology Group
Amgen
Medical College of Wisconsin
Children's Oncology Group
Fred Hutchinson Cancer Center
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Case Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Therapeutic Advances in Childhood Leukemia Consortium
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
Medical College of Wisconsin
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
Goethe University
Goethe University
Goethe University
Goethe University
St. Jude Children's Research Hospital
SWOG Cancer Research Network
SWOG Cancer Research Network
Medical College of Wisconsin
Children's Oncology Group